-
Retirement
Savers Competition Can Really Help Low- and Middle-income Workers – Retirement Research Center
Promote its availability, automatic admission and ensure easy access to state-automatic IRA participants is key to success. I have always…
Read More » -
FRAUD PREVENTION
Data beats instincts in the competition to surpass fraudsters
Real-time payments are exciting for consumers and businesses with immediate fund transfers, but the same speed attracts fraudsters. Banks eager…
Read More » -
HEALTHCARE & MEDICARE
However, it moved – Healthcare Blog
Kim Bellard Science enthusiasts will recognize the title as (probably pseudo-Scripture) citing Galileo’s claim to be forced to withdraw his…
Read More » -
FRAUD PREVENTION
Regulators' phone calls Spurs comments on payment fraud
Fraud continues to plague payment systems – and regulatory agencies Require Answer. Banks, credit unions and payment networks respond to…
Read More » -
HEALTHCARE & MEDICARE
Capital RX rebrands into Judi Health, earning $400 million investment
The company announced Tuesday that transparent pharmacy benefits manager Capital RX has received a $400 million investment and has been…
Read More » -
HEALTHCARE & MEDICARE
Ionis Pharma's Rare Disease Drugs Not Approved Therapy Meets Critical Research Targets
Patients with specific genetic disorders whose symptoms include a progressively worsening muscle control can walk faster after experimental Ionis Pharmaceuticals…
Read More » -
HEALTHCARE & MEDICARE
Promote, not information, for participation and adoption
You have groundbreaking medical devices or digital health applications and data to show improved health outcomes or lower costs. You…
Read More » -
HEALTHCARE & MEDICARE
New bereavement cost calculator shows that sadness is expensive – Healthcare Blog
Emma Payne Sadness is expensive. In addition to major human impacts, studies have shown that bereavement leads to a 20%-30%…
Read More » -
HEALTHCARE & MEDICARE
AI hallucinations: What are they, always terrible?
Hallucinations are a regular focus of conversations about healthcare AI. But what do they actually mean in practice? This is…
Read More » -
HEALTHCARE & MEDICARE
Pfizer's $4.9B Metsera acquisition makes it a major player in obesity drugs and more people
Pfizer's internal obesity drug development stumbled upon, but the drug giant passed a billion-dollar acquisition of the multi-billion-dollar clinical-stage company…
Read More »